Which Patients with Pulmonary Embolism Will Have Complications?

A new risk score attempts to stratify PE patients into risk groups, but is this clinically useful?

Most patients with pulmonary embolism (PE) do well, and outpatient management is becoming more common. Predicting which patients will have complications would be valuable in order to triage patients for discharge or admission to a ward or intensive care unit and for recanalization or simple anticoagulation. The previously derived Bova score (Eur Respir J 2014; 44:694) stratifies patients with PE and systolic blood pressure >90 mm Hg into risk groups by assigning points for four variables: hypotension (systolic blood pressure 90–100 mm Hg, 2 points), tachycardia (heart rate ≥110 beats per minute, 1 point), troponin elevation (2 points), and right ventricular dysfunction on computed tomography or echocardiography (2 points). Now, the investig…

Reviewing Author

Daniel J. Pallin, MD, MPH

Disclosures

Consultant/Advisory BoardPortola Pharmaceuticals, Inc.

Speaker’s BureauPeerView Institute for Medical Education

Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals

Daniel J. Pallin, MD, MPH

Disclosures

Consultant/Advisory BoardPortola Pharmaceuticals, Inc.

Speaker’s BureauPeerView Institute for Medical Education

Which Patients with Pulmonary Embolism Will Have Complications?

Topics

Reviewing Author